Oregon Public Employees Retirement Fund Has $4.29 Million Stock Holdings in Cardinal Health, Inc. $CAH

Oregon Public Employees Retirement Fund boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 32.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,334 shares of the company’s stock after purchasing an additional 6,693 shares during the quarter. Oregon Public Employees Retirement Fund’s holdings in Cardinal Health were worth $4,290,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CAH. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Cardinal Health by 3.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after buying an additional 62 shares during the last quarter. Kathmere Capital Management LLC raised its holdings in Cardinal Health by 1.6% in the 3rd quarter. Kathmere Capital Management LLC now owns 4,091 shares of the company’s stock valued at $642,000 after acquiring an additional 65 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in Cardinal Health by 0.4% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock valued at $2,991,000 after acquiring an additional 69 shares during the period. Vermillion & White Wealth Management Group LLC lifted its position in Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 71 shares during the last quarter. Finally, Perigon Wealth Management LLC boosted its holdings in shares of Cardinal Health by 3.2% during the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock worth $389,000 after acquiring an additional 72 shares during the period. 87.17% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on CAH. Wells Fargo & Company upped their target price on Cardinal Health from $185.00 to $221.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Leerink Partners boosted their price target on Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. Evercore ISI increased their price objective on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research report on Friday, October 31st. UBS Group lifted their target price on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Finally, Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a research report on Friday, October 31st. Fourteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $212.60.

Cardinal Health Price Performance

Cardinal Health stock opened at $201.06 on Friday. The firm has a market cap of $47.77 billion, a PE ratio of 30.33, a price-to-earnings-growth ratio of 1.46 and a beta of 0.65. The stock’s fifty day moving average price is $204.05 and its two-hundred day moving average price is $173.16. Cardinal Health, Inc. has a one year low of $119.25 and a one year high of $214.93.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company’s revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.